Breast cancer drug overloads tumors with toxic “surge”

An experimental drug targeting triple-negative breast cancer overwhelms cancer cells with toxic fats, according to a new study led by UF College of Medicine Professor Satya Narayan, Ph.D. While early results are promising, additional trials are needed to determine the safety and effectiveness of the drug for humans.

Visit the UF News website to learn more.